FDA approves first chikungunya vaccine for people over 18
Nov 11, 2023, at 05:31 am
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, for people above 18 and older at increased risk of exposure to the mosquito-borne virus.
FDA approves first Respiratory Syncytial Virus vaccine
May 04, 2023, at 02:31 pm
The U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States.
Regulators suspend prodn of Global Pharma Healthcare's ophthalmic range of products: Reports
Feb 06, 2023, at 02:44 am
Chennai-based Global Pharma Healthcare has been asked to stop the production of its ophthalmic range of products after a joint inspection of Central Drugs Standard Control Organisation (CDSCO) and the State Drug Controller of its production site on Friday, media reports said.
US drug regulator approves Pfizer's Covid pill for people aged 12 and above
Dec 23, 2021, at 05:32 am
Washington/IBNS: The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over.
US approves Pfizer-BioNTech Covid booster for teenagers aged 16 and 17
Dec 10, 2021, at 06:07 am
Washington/IBNS: The United States Food and Drug Administration (FDA) on Thursday authorised the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant.
US FDA denies India’s Covaxin emergency use approval; seeks additional clinical trial data
Jun 12, 2021, at 05:13 am
Hyderabad/UNI:India’s indigenous Covid vaccine ‘Covaxin’ developed by Hyderabad-based Bharat Biotech (BB), will be delayed to launch in the US market as US Food and Drug Administration (FDA) asked ‘Ocugen Inc ‘ the US partner of the BB, to pursue a biological Applications (BLA) path for ‘Covaxin,’ which is full approval.
US health regulator calls for pause in Johnson & Johnson vaccine use after cases of rare blood clots
Apr 14, 2021, at 04:27 am
Washington/IBNS: US's federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine after several cases of a rare and severe type of blood clot were reported among 6.8 million people who received the vaccine.